
The pharmaceutical company Yugmedpharm has successfully passed the audit of the Ministry of Industry and Trade of the Russian Federation for compliance with the requirements of the Good Manufacturing Practice Rules of the Eurasian Union and received the GMP certificate of the EAEU (GMP/EAEU/RU/01337-2024).
The GMP certificate is a confirmation of the proper operation of the pharmaceutical system of the plant and a guarantee of the safety and effectiveness of drugs produced in the future. Obtaining a certificate will allow the pharmaceutical company to register and sell drugs in the markets of Russia, Armenia, the Republic of Belarus, Kazakhstan and Kyrgyzstan.
Information on certificates issued to the company in the form of the European Union is published in the state register on the website of the Ministry of Industry and Trade.